Vicken Karagoezian
Vicken Karageozian , MD, has been named president and CEO of Allegro Ophthalmics, while co-founder and former CEO Hampar Karageozian has been named executive chairman, according to a company press release.
As president and CEO, Vicken Karageozian, who co-founded Allegro as well as Ista Pharmaceuticals and Vitreoretinal Technologies, will lead the company as it prepares its diabetic macular edema treatment Luminate (risuteganib) for phase 3 clinical trials, the release said.
He previously served as Allegro’s president and chief medical officer and is the inventor or
Uncategorized